Over one year in 20 national-team endurance athletes, each Readiness Advisor app question correlated with its counterpart measure (r = 0.39 to 0.81), but time-series analysis showed marked individual variability. With only 20 athletes, the results cannot be assumed to hold for other athletes or for recreational exercisers.
A scoping review of 2385 records found only 19 studies that used wearables with AI for real-time detection or prediction of cardiovascular events, and most relied on public datasets rather than real-world validation. It maps what exists and does not measure how well any of these systems work.
In 2,497 older adults in Nanchang, China, 23.30% had depressive tendencies and 44.90% anxiety tendencies, and both low physical activity and poor sleep were associated with higher odds of each. A single-time survey cannot show cause and effect, and the abstract gives the odds ratios without confidence intervals.
In a survey of 1,452 female Chinese university students, social anxiety partly linked self-rated health to physical activity, accounting for 12% of the total effect (CI 0.011 to 0.090). A single cross-sectional survey cannot show which factor comes first, and activity was captured with one self-report item.
Across 85 prospective studies, adults whose physical activity was consistently high or increasing had around 20-40% lower risk of all-cause mortality and 30-40% lower risk of cardiovascular mortality. These are observational findings with self-reported activity patterns, and the links with decreasing activity and with cancer deaths were weaker.
A narrative review found high diagnostic accuracy for arrhythmia detection and promising results in heart failure monitoring from AI-enabled wearables, particularly FDA- or CE-approved devices. Most studies were small, short-term and in controlled settings, and the review reports no pooled numbers.
Pooling 11 randomised trials with 549 participants, sleep deprivation was associated with lower rMSSD (p < 0.05) and higher LF and LF/HF (p < 0.05), while the changes in SDNN and HF were not statistically significant (p > 0.05). Trials differed in how HRV was measured and how long sleep was withheld, and the abstract gives no effect sizes.
In 72 studies with 7949 participants, wearables used at home to monitor movement were generally well accepted, with compliance of 70% or more and strong agreement with clinical assessments. Only half of the studies were controlled trials and just 5.6% were randomised, so evidence that they improve care is limited.
In 931 adults at a US medical centre, pulse rate variability from a light-based (PPG) sensor disagreed significantly with ECG-based heart rate variability (p < 0.001 for all) and underestimated SDNN, rMSSD and pNN50 in several chronic disease groups. The sample was patients wearing one research device, so other wearables and healthy users may differ.
Pooling 21 randomised trials, exercise programmes improved adolescents' cognition, for example attention (SMD 0.56, 90% CI 0.34 to 0.78) and executive function (SMD 0.21, 0.06 to 0.37), with aerobic exercise showing the largest effect (SMD 0.53). Trials used varied tests and exercise types, so the pooled figures describe an average of quite different programmes.
Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.
Among 106 asymptomatic male cyclists and triathletes aged 50 or older, 50 (47.2%) had myocardial fibrosis on MRI, and fibrosis was linked to a higher hazard of ventricular arrhythmia on a loop recorder (HR 4.7, 95% CI 1.8-12.8) over a median 720 days. Few men, short follow-up and a wide interval make this a signal, not a risk calculator.
Among 36 251 UK Biobank participants followed for a median of 13.9 years, a rise in visit-to-visit systolic blood pressure variability was associated with a 23%-33% higher risk of cardiovascular disease, coronary heart disease, stroke, chronic kidney disease and death. It is an observational association, and the readings were taken from health records before enrolment, not from a standard protocol.
A review of 41 studies (from 239 identified) found consistent evidence linking reduced heart rate variability with the severity of obstructive sleep apnea (OSA) and COPD, and more pronounced changes in overlap syndrome. The authors' view that HRV is a valuable clinical tool goes beyond what a narrative literature review can prove.
A scoping review of 109 studies mapped wearables used for health promotion in older adults, with mobility, mental health, falls, arrhythmia detection, activity recognition and sleep monitoring the most common targets. Most studies were application design or observational work, so the review shows what has been studied rather than what works.
In 352 women with depression tracking via the Juli app (9393 entries), mood declined gradually from 14 days before menstruation and was lowest from 3 days before to 2 days after (54.3% scored lower in that window, 95% CI 48.9% to 59.6%). Energy did not vary with cycle day, and the app-based self-ratings come from a self-selected group.
In 278 participants, those with metabolic syndrome had lower sample entropy and DFA values at rest than people without metabolic alterations, and sample entropy was already lower with one or two alterations. The abstract gives no accuracy or prediction statistics, so this does not show HRV can detect metabolic syndrome.
In 19 young women, 20 young men and 14 elderly men, a single bout of strength training or high-intensity interval training raised blood levels of Klotho, BDNF and GPLD1, regardless of sex or age. These are short-lived blood markers measured in a small group, not proof of any cognitive benefit.